Blog
  • Omnichannel
  • Oncology
  • Conferences
  • Media Tracking
  • Ferma.AI
  • Launch Excellence
  • HCP-PT
  • Talent Community
Varsha Sundaram

Varsha Sundaram

10 posts •
Immunology Pharma Manufacturer Perception Report - Q2'25
Promotional Tracking

Immunology Pharma Manufacturer Perception Report - Q2'25

Executive Summary In the ever-evolving pharmaceutical industry, the perception of healthcare professionals (HCPs) can make or break a company's success. Understanding what HCPs value and how they perceive different pharma manufacturers is essential

  • Varsha Sundaram
    Varsha Sundaram
5 min read
Unveiling the Mindshare Battle in Psychiatric Drugs
Promotional Tracking

Unveiling the Mindshare Battle in Psychiatric Drugs

What drives Psychiatrists’ Awareness and Excitement in a space with multiple alternatives? Executive Summary The psychiatric drug market is fiercely competitive, with healthcare professionals (HCPs) navigating a crowded landscape of approved and pipeline

  • Varsha Sundaram
    Varsha Sundaram
  • Neen Anna Alexander
6 min read
Global Pharma Manufacturer Perception Tracker Oncology
Oncology

Global Pharma Manufacturer Perception Tracker Oncology

Every day, over 54,500 people are diagnosed with cancer and more than 26,000 succumb. Pharma leaders are answering the call by increasing investments in cancer drug research and developing personalized treatments,

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Neen Anna Alexander
2 min read
Global Pharma Manufacturer Perception: Vaccines
Promotional Tracking

Global Pharma Manufacturer Perception: Vaccines

The vaccine industry has undergone an unprecedented transformation in the last 5 years, driven by significant technological advancements and a renewed global focus on public health and immunization. Breakthroughs in multiple areas like

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Neen Anna Alexander
2 min read
Factor XIa Inhibitors for NVAF - Cardiologists' Perspectives
Promotional Tracking

Factor XIa Inhibitors for NVAF - Cardiologists' Perspectives

Key Findings •Eliquis is currently the top choice for stroke prevention in NVAF, being used in 56% of patients, followed by Xarelto at 26% • Mirroring usage, 77% of cardiologists perceive Eliquis as performing

  • Varsha Sundaram
    Varsha Sundaram
  • Nick Fleischman
    Nick Fleischman
2 min read
Four Myths in HCP-Sales Rep Engagements
Promotional Tracking

Four Myths in HCP-Sales Rep Engagements

Stirring the Hornet’s Nest Engaging with healthcare professionals (HCPs) through sales representative interactions is like a delicate dance. There are established norms & firm beliefs on how it is being done. Challenging those

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Akshay Kanna
    Akshay Kanna
4 min read
Thriving Against the Odds - A Case study
Promotional Tracking

Thriving Against the Odds - A Case study

An Emerging Biopharma’s David vs. Goliath story in the Post Launch Space Problem: Respiratory diseases are one of the leading causes of death and hospital admissions in the US. This market is

  • Varsha Sundaram
    Varsha Sundaram
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
1 min read
Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape
Promotional Tracking

Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape

Highlight products’ superiority and differentiability Your browser does not support the audio element. Answer questions and/or solve problems Your browser does not support the audio element. Deliver newer data, such as product

  • Varsha Sundaram
    Varsha Sundaram
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
17 min read

President Biden Signed a $1.7 Trillion Spending Bill; Here’s What It Means for Your Healthcare

Just before funding for the federal government was set to expire, President Joe Biden signed the Consolidated Appropriations Act of 2023. The nearly $1.7 trillion federal spending bill averts a government shutdown

  • Varsha Sundaram
    Varsha Sundaram
2 min read
Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021
Research

Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021

Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions. In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists

  • Ben Maimon
    Ben Maimon
  • Varsha Sundaram
    Varsha Sundaram
5 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS